Pharmather Holdings Ltd PHRRF

Buzz on the Bullboards: Major developments amidst market dynamics

[Jonathon Brown]

Several TSX-listed companies are making headlines with significant updates, strategic movements and quarterly reports. read article.

[PressRelease]

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a company that is forty-nine percent (49%) owned by PharmaTher and fifty-one...read article.

[TheLandedEagles]

They are playing with everyone here..as with all these penny stocks most investors/traders they have stop-loss orders, and they see these potential sell orders in the seque and rush in on these tpye

[TheLandedEagles]

PharmaTher received that final Complete Response Letter, and PharmaTher responded with their comments and further testing with their thoughts of deficientcies and positive results. This is only GOOD

[PressRelease]

The FDA Assigned Goal Date is October 29, 2024 TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced receipt of an Amendment Acknowledgment Letter (“AAL”) for its Priority...read article.

[TheLandedEagles]

Sorry my error...warrants are showing to be 16.8mm out at a exercise price of .80 cents...this could bring in potential cash funds of $13.4mm...NOT the $6mm indicated. See web "presentation"

[PressRelease]

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a company that is forty-nine percent (49%) owned by PharmaTher and fifty-one...read article.

[TheLandedEagles]

Glloyd...respectfully, go look at last recent public releases.. will provide you the info you need !!!!!

[Glloyd]

I thought the FDA was supposed to be approved today the 29th. Any ideas why it hasn't been and there's no update or anything?

[Itistoo]

They are actually closer to 2 mil in the bank right now, so they really need to get this approval sooner than later.  Just as important as that they need to have clients and sales lined up. If

[TheLandedEagles]

Investors looking for Big Rewards with minimal risk at this late stage of a FDA imminent approval,...needs to have a locked-in share position in PharmaTher....Hugh upside very soon. Look to the

[TheLandedEagles]

For sure...thats how I see things here for PHRM. Short and long term, this company will be huge in valuation. Time will only tell of coarse. Thats why I'm in and accumulating a very large position

[BradlTheGerman]

The article describes very well that ketamine can help in many areas of medicine, but that this fails due to regulations, among other things.   If the FDA grants approval, which I assume it

[BradlTheGerman]

Why low-cost ketamine is still inaccessible to many with severe depression A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for

[TheLandedEagles]

Well...only God knows!!!...I dont give price predictions. Do know, in my opinion...PHRM, is drastically under valued today with its market valuation and with the anticipated near term probable FDA

[Sailormark]

How high will it go?